{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:54:41Z","timestamp":1769270081976,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,27]]},"DOI":"10.7759\/cureus.72510","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:41:12Z","timestamp":1730094072000},"source":"Crossref","is-referenced-by-count":3,"title":["Intact Parathyroid Hormone (iPTH) Assay: An Early Approach for Bone Health Assessment in Chronic Renal Failure"],"prefix":"10.7759","author":[{"given":"Sweta","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prit P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020, 395:709-33. 10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850\u00a0million individuals have kidney diseases","volume":"96","author":"Jager KJ","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850\u00a0million individuals have kidney diseases. Kidney Int. 2019, 96:1048-50. 10.1016\/j.kint.2019.07.012","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000332757","article-title":"Prevalence of subclinical hypothyroidism in patients with end-stage renal disease and the role of serum albumin: a cross-sectional study from South India","volume":"1","author":"Shantha GP","year":"2011","unstructured":"Shantha GP, Kumar AA, Bhise V, Khanna R, Sivagnanam K, Subramanian KK. Prevalence of subclinical hypothyroidism in patients with end-stage renal disease and the role of serum albumin: a cross-sectional study from South India. Cardiorenal Med. 2011, 1:255-60. 10.1159\/000332757","journal-title":"Cardiorenal Med"},{"key":"ref4","article-title":"Chronic Kidney Disease","author":"Vaidya SR","year":"2024","unstructured":"Vaidya SR, Aeddula NR. Chronic Kidney Disease. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello AK","year":"2017","unstructured":"Bello AK, Alrukhaimi M, Ashuntantang GE, et al.. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl (2011). 2017, 7:122-9. 10.1016\/j.kisu.2017.07.007","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5496710","article-title":"Parathyroid hormone measurement in chronic kidney disease: from basics to clinical implications","volume":"2019","author":"Kritmetapak K","year":"2019","unstructured":"Kritmetapak K, Pongchaiyakul C. Parathyroid hormone measurement in chronic kidney disease: from basics to clinical implications. Int J Nephrol. 2019, 2019:5496710. 10.1155\/2019\/5496710","journal-title":"Int J Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9619253","article-title":"Parathyroid hormone fragments: new targets for the diagnosis and treatment of chronic kidney disease-mineral and bone disorder","volume":"2018","author":"Chen H","year":"2018","unstructured":"Chen H, Han X, Cui Y, Ye Y, Purrunsing Y, Wang N. Parathyroid hormone fragments: new targets for the diagnosis and treatment of chronic kidney disease-mineral and bone disorder. Biomed Res Int. 2018, 2018:9619253. 10.1155\/2018\/9619253","journal-title":"Biomed Res Int"},{"key":"ref8","article-title":"Approach to hypercalcemia","author":"Goltzman D","year":"2000","unstructured":"Goltzman D. Approach to hypercalcemia. Endotext [Internet]. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijcbr.2020.063","article-title":"Secondary hyperparathyroidism in patients with chronic kidney disease: a case control study","volume":"7","author":"Natikar JA","year":"2020","unstructured":"Natikar JA, Shailaja A. Secondary hyperparathyroidism in patients with chronic kidney disease: a case control study. Int J Clin Biochem Res. 2020, 7:291-6. 10.18231\/j.ijcbr.2020.063","journal-title":"Int J Clin Biochem Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb03001.x","article-title":"Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency","volume":"47","author":"Bruce DG","year":"1999","unstructured":"Bruce DG, St John A, Nicklason F, Goldswain PR. Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J Am Geriatr Soc. 1999, 47:354-9. 10.1111\/j.1532-5415.1999.tb03001.x","journal-title":"J Am Geriatr Soc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go AS","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351:1296-305. 10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"ref12","article-title":"Current issues in the management of secondary hyperparathyroidism and bone disease","volume":"21 Suppl 3","author":"Moe SM","year":"2001","unstructured":"Moe SM. Current issues in the management of secondary hyperparathyroidism and bone disease. Perit Dial Int. 2001, 21 Suppl 3:S241-6.","journal-title":"Perit Dial Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024, 105:S117-314. 10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita K","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, et al.. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015, 3:514-25. 10.1016\/S2213-8587(15)00040-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor BC","year":"2011","unstructured":"Astor BC, Matsushita K, Gansevoort RT, et al.. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011, 79:1331-40. 10.1038\/ki.2010.550","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort RT","year":"2011","unstructured":"Gansevoort RT, Matsushita K, van der Velde M, et al.. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011, 80:93-104. 10.1038\/ki.2010.531","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde M","year":"2011","unstructured":"van der Velde M, Matsushita K, Coresh J, et al.. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011, 79:1341-52. 10.1038\/ki.2010.536","journal-title":"Kidney Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen TK","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019, 322:1294-304. 10.1001\/jama.2019.14745","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-10","article-title":"What do we know about chronic kidney disease in India: first report of the Indian CKD registry","volume":"13","author":"Rajapurkar MM","year":"2012","unstructured":"Rajapurkar MM, John GT, Kirpalani AL, et al.. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012, 13:10. 10.1186\/1471-2369-13-10","journal-title":"BMC Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1777_19","article-title":"Relationship between liver function tests & cardiovascular risk factors in stage 3-5 pre-dialysis chronic kidney disease","volume":"155","author":"Selen T","year":"2022","unstructured":"Selen T, Akoglu H, Agbaht K. Relationship between liver function tests & cardiovascular risk factors in stage 3-5 pre-dialysis chronic kidney disease. Indian J Med Res. 2022, 155:397-402. 10.4103\/ijmr.IJMR_1777_19","journal-title":"Indian J Med Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15569","article-title":"Influencing factors of cardiac valve calcification (CVC) in patients with chronic kidney disease and the impact of CVC on long-term prognosis: a single-center retrospective study","volume":"11","author":"Wang J","year":"2023","unstructured":"Wang J, Xiao J, Wang R, Wang D. Influencing factors of cardiac valve calcification (CVC) in patients with chronic kidney disease and the impact of CVC on long-term prognosis: a single-center retrospective study. PeerJ. 2023, 11:e15569. 10.7717\/peerj.15569","journal-title":"PeerJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_279_18","article-title":"Correlation of parathyroid hormone levels with mineral status in end-stage renal disease patients","volume":"22","author":"Arora K","year":"2018","unstructured":"Arora K, Goyal G, Soin D, Kumar S, Arora H, Garg C. Correlation of parathyroid hormone levels with mineral status in end-stage renal disease patients. Indian J Endocrinol Metab. 2018, 22:735-9. 10.4103\/ijem.IJEM_279_18","journal-title":"Indian J Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S282106","article-title":"Correlation between parathyroid hormone levels with urinary magnesium excretion in patients with non-dialysis dependent chronic kidney disease","volume":"13","author":"Carneiro Dias RS","year":"2020","unstructured":"Carneiro Dias RS, Jos\u00e9 de Ara\u00fajo Brito D, Milhomem Dos Santos E, et al.. Correlation between parathyroid hormone levels with urinary magnesium excretion in patients with non-dialysis dependent chronic kidney disease. Int J Nephrol Renovasc Dis. 2020, 13:341-8. 10.2147\/IJNRD.S282106","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.25100\/cm.v50i1.4444","article-title":"Erratum: vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5","volume":"50","author":"Restrepo Valencia CA","year":"2019","unstructured":"Restrepo Valencia CA, Aguirre Arango JV. Erratum: vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. Colomb Med (Cali). 2019, 50:49. 10.25100\/cm.v50i1.4444","journal-title":"Colomb Med (Cali)"},{"key":"ref25","article-title":"Correlation of secondary hyperparathyroidism with chronic kidney disease and its stages","volume":"9","author":"Deepthi N","year":"2021","unstructured":"Deepthi N, Dhandapani E, Radhakrishnan A. Correlation of secondary hyperparathyroidism with chronic kidney disease and its stages. J Res Med Dent Sci. 2021, 9:298-303.","journal-title":"J Res Med Dent Sci"},{"key":"ref26","article-title":"Hyperparathyroidism in chronic kidney disease","author":"Dr\u00fceke TB","year":"2021","unstructured":"Dr\u00fceke TB. Hyperparathyroidism in chronic kidney disease. Endotext [Internet]. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2021."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306310-intact-parathyroid-hormone-ipth-assay-an-early-approach-for-bone-health-assessment-in-chronic-renal-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:41:13Z","timestamp":1730094073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306310-intact-parathyroid-hormone-ipth-assay-an-early-approach-for-bone-health-assessment-in-chronic-renal-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.72510","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,27]]}}}